Health
As variants threaten Covid-19 progress, US weighs trial results of Johnson & Johnson vaccine candidate – CNN International
As worrisome Covid-19 variants are increasingly found in the United States, experts say Johnson & Johnson’s vaccine candidate would help in the pandemic fight,…
(CNN)As worrisome Covid-19 variants are increasingly found in the United States, experts say Johnson & Johnson’s vaccine candidate would help in the pandemic fight, despite trial reports showing apparently lower efficacy rates than two vaccines already authorized in the US.
Johnson & Johnson’s single-shot coronavirus vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3 trial and 85% effective against severe disease, the company announced Friday. It…
-
Noosa News12 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Business14 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
General21 hours agoHopes for peace but pain lingers on Oct 7 anniversary
-
General11 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse